tm logo
ORBBO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 14 Jan 2019

Last Applicant/ Owned by

225 S. GRAND AVE, #1214

LOS ANGELES

US

CA

90012

Serial Number

86821982 filed on 16th Nov 2015

Registration Number

N/A

Correspondent Address

STEPHEN L. HUMPHREY

CAMERON LLP

STE 1003

818 CONNECTICUT AVE NW

WASHINGTON, DC 20006

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ORBBO

Robotic exoskeletal systems for medical use by humans, namely, robotic artificial limbs Allograft materials, namely, human tissue based skin allograft; hemostatic sealants, namely, medical hemostatic paste, hemostatic gel matrix preparations for treating wounds and hemostatics for medical purposes; orthopedic implants comprising living tissue

Classification Information


Class [005]
Pharmaceutical Products


Allograft materials, namely, human tissue based skin allograft; hemostatic sealants, namely, medical hemostatic paste, hemostatic gel matrix preparations for treating wounds and hemostatics for medical purposes; orthopedic implants comprising living tissue

Class [010]
Medical Instrument Products


Robotic exoskeletal systems for medical use by humans, namely, robotic artificial limbs

Mark Details


Serial Number

No 86821982

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Jan 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
14th Jan 2019ABANDONMENT - NO USE STATEMENT FILED
15th Jun 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Jun 2018EXTENSION 3 FILED
13th Jun 2018EXTENSION 3 GRANTED
13th Jun 2018TEAS EXTENSION RECEIVED
07th May 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12th Mar 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
15th Dec 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Dec 2017EXTENSION 2 GRANTED